Go to content

Understanding the renal cell carcinoma patient population in Ontario: cancer summary report

Client: IQVIA Solutions Canada Inc.

Project ID: P2022-107 / 2023 0970 305 000

Research Question/Objectives: Renal Cell Carcinoma (RCC) is the most common type of kidney cancer, and accounts for approximately 2% of new cancers. As the disease progresses, RCC can be treated with nephrectomy and drug therapies such as immunotherapy and targeted therapy. Despite its relatively high burden, the population burden of RCC is not well described in the published literature, especially as the disease progresses. The proposed study looks to quantify the disease burden of RCC along the RCC patient journey using administrative data health at ICES.

Research objectives:

  • Identify RCC patients and their distribution by disease progression within the health administrative data held at ICES.
  • Describe the characteristics of these cancer patients in Ontario, including: incidence (i.e., new patients); prevalence (i.e. existing patients); and demographic and clinical characteristics.


  • August 2023